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19.7
A tissue engineered hybrid construct for osteochondral 
reconstruction: a biomechanical analysis
N. O‘Sullivan1, M. Ranka2, K. Zaleski2, M. Yaremchuk2, L. Bonasser3,
M. Randolph2;
1Department Of Plastic Surgery, Massachusetts General Hospital 
and Harvard Medical School, Boston, MA, United States of America, 
2Plastic Surgery, Massachusetts General Hospital and Harvard 
Medical School, Boston, MA, United States of America, 3Department
Of Biomedical Engineering, Cornell, Ithaca, NY, United States of 
America
Purpose: An inert and biocompatible material could provide an ‚off 
UIF TIFMG´ DVTUPNJ[BCMF TDBGGPME PGGFSJOH TUBCJMJUZ PG ¾YBUJPO BOE
integrative repair of joints secondary to trauma or degenerative 
disease. We propose a tissue engineered composite, combining the 
biological advantages of engineered cartilage with the mechanical 
advantages of porouspolyethylene (PPE). Adherence and integration 
of engineered cartilage at the repair site is crucial for stability of the 
repair. We assess the ability of PPE to support the growth of articular 
cartilage and the biomechanical integrity of the bond formed. 
Methods and Materials: Porcine articular chondrocytes were isolated 
BOE TVTQFOEFE JO ¾CSJO HFM QPMZNFS BU Y6cells/cc and placed 
between 6mm discs of PPE forming tri-layer constructs. Control 
TBNQMFTPG¾CSJOHFMPSIVNBOEFSNBM¾CSPCMBTUTBMPOFXFSFBMTP
made. The constructs were implanted into nude mice for 6, 12, and 18 
weeks. Specimens were evaluated for neo-cartilage production and 
integration into PPE substrate with histological, biochemical, and 
biomechanical analysis. 
Results: 0OMZ¾CSPVTUJTTVFGPSNFEJOUIF¾CSJODPOUSPMTBOEDPOUSPMT
XJUI¾CSPCMBTUT/FXDBSUJMBHFNBUSJYXBTGPSNFEJOBMMTBNQMFTXJUI
chondrocytes and the neocartilage integrated with the PPE. Integration 
strength increased over time. Similar trends were observed in failure 
energy and tensile modulus. Ultimate tensile strength values for 
experimental samples were increased (p>0.05) from 6 to 18 weeks 
and exceeded those of controls (p>0.05). 
Conclusions: Articular chondrocytes can produce new cartilaginous 
matrix in vivo that forms mechanically functional bonds with PPE. 
5IFTF¾OEJOHTNBZIBWFQPTJUJWFJNQMJDBUJPOTGPSUJTTVFFOHJOFFSFE
articular cartilage for joint resurfacing and reconstruction. 
20.3
Phenotypically stable chondrocytes are superior in activating 
cartilage regeneration processes in goat condyle lesions
A. Jahraus1, H. Vanhauwermeiren1, A. Lundqvist2, J. Neys1,
G. Vanderlinden1, P. Tomme1, F. Luyten3, A. Knipper1;
1R&D Department, TiGenix NV, Leuven, Belgium, 2R&D Department, 
TiGenix, Leuven, Belgium, 3Rheumatology, University Hospital 
Leuven, Leuven, Belgium
Purpose: The ChondroCelect® DPODFQU JT CBTFE PO UIF TDJFOUJ¾D
rationale that phenotypically stable chondrocytes, in contrast to 
cells which have (partially) lost their chondrogenic commitment, 
resist antagonistic environmental signals in the joint and hence, may 
activate superior regenerative processes leading to hyaline cartilage 
when implanted into articular cartilage defects. 
Methods and Materials: Goat chondrocytes cultured according to 
the ChondroCelect® culture process and phenotypically instable, de-
differentiated chondrocytes were injected both into the muscle of 
nude mice and implanted into critical size articular cartilage defects 
PGUIFDBQSJOFNFEJBMGFNPSBMDPOEZMF(PBUTXFSFTBDSJ¾DFEBGUFS
and 52 weeks and neo-tissue formation throughout the entire defect 
was histologically evaluated. 
Results: Ten weeks post-implantation, ChondroCelect®-like 
chondrocytes were capable of forming hyaline-like cartilage in nude 
mice muscles and showed superior repair capacity in goats compared 
to the phenotypically instable chondrocytes, as demonstrated 
by a homogeneous repair in the defect center, superior tissue 
integration, increased cellularity in the periphery and a 2-fold higher 
MOD score. Cartilage regeneration activated by ChondroCelect®-
like chondrocytes seemed to involve native tissue remodeling 
supplying evidence for communication between implanted cells and 
native cartilage. The overall cartilage quality further improved with 
prolonged treatment time. 
Conclusions: ChondroCelect®-like chondrocytes demonstrated an 
improved structural repair in an orthotopic animal model compared 
to control cells without stable chondrogenic commitment. The MOD 
score obtained in goats showed a positive correlation with the 
histology score for implants obtained from the same cell preparations 
in nude mice and hence, validated the nude mouse assay as tool to 
predict outcomes in the orthotopic environment. 
20.4
"OUBHPOJTUTPGUIFIZQFSUSPQIJDEJGGFSFOUJBUJPOQBUIXBZJO¿VFODF
in vitro chondrogenesis of human mesenchymal stem cells
E. Steck1, T. Hennig2, R. Bock1, S. Weiss3, W. Richter2;
1Division Of Experimental Orthopaedics, Orthopaedic University 
Hospital Heidelberg, Heidelberg, Germany, 2Division Of Experimental 
Orthopaedics, Orthopaedic Clinic, University of Heidelberg, 
heidelberg, Germany, 3Orthopädie I, Orthopaedic University 
Hospital Heidelberg, Heidelberg, Germany
Purpose: Mesenchymal stem cells (MSC) represent an attractive 
cell source for the treatment of articular cartilage defects. Common 
in vitro chondrogenic differentiation protocols, however, initiate a 
QBUIXBZSFMBUFEUPFOEPDIPOESBMPTTJ¾DBUJPOJODMVEJOHJOEVDUJPOPG
hypertrophy, leading to transient ectopic cartilage which undergoes 
DBMDJ¾DBUJPOBOENJDSPPTTJDMFGPSNBUJPOJOWJWP5IJTTUVEZBJNFEUP
analyse the effects of known antagonists on in vitro chondrogenesis 
of MSC in order to learn to induce a chondrocyte phenotype similar 
UPTUBCMFBSUJDVMBSDBSUJMBHFXIJDISFTJTUTDBMDJ¾DBUJPOJOWJWP
Methods and Materials: MSC were induced for up to 42 days in 
serum-free medium supplemented with dexamethasone and TGFȕ-
3 in micromass culture. Additionally modulators of the BMP and 
IHH signalling-pathways were added. Chondrogenic differentiation 
and hypertrophy were assessed by alcian-blue and collagen type-
I, -II and -X-staining accompanied by comparative geneexpression 
analyses. Additionally ALP-activity was determined. 
Results: Depending on the time frame exogenous application of 
two known inhibitors prevented chondrogenic differentiation or 
modulated only collagen type-X deposition and ALP-activity in 
DIPOESPHFOJDBMMZJOEVDFE.4$(FOFFYQSFTTJPOBOBMZTJTDPO¾SNFE
the down-regulation of late hypertrophic markers while cartilage 
typical molecules were almost unaffected. The application of basic 
FGF, a negative regulator of chondrogenic differentiation, also 
reduced the ALP-activity when supplementation was delayed. 
Conclusions: The suppression of hypertrophic development is the 
basis for the clinical application of MSC to treat cartilage defects. 
Promising results to suppress the hypertrophic phenotype without 
JO¿VFODJOHUIFDIPOESPHFOJDEJGGFSFOUJBUJPOQPUFOUJBMXFSFPCUBJOFE
by the application of inhibitors of the BMP and IHH pathway. 
20.5
In vitro characterization of human embryonic stem cell derived 
Mesenchymal progenitors (hES-MP)
K. Kajic1, N. Bigdeli1, K. Emanuelsson2, R. Strehl3, A. Lindahl4;
1Department Of Clinical Chemistry And Transfusion Medicine, 
Institute of Biomedicine, Gothenburg, Sweden, 2Cellartisab, Cellartis 
AB, Gothenburg, Sweden, 3Cellartis Ab, Cellartis AB, Gothenburg, 
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Purpose: Mesenchymal progenitor cell lines were derived from 
different human embryonic stem (hES) cell lines at Cellartis 
AB, Gothenburg, Sweden. We investigated the mesodermal 
differentiation potential of hES-MPs in vitro. 
Methods and Materials: We have chosen two different hES-MP 
cell lines SA167 and SA002.5 for characterization and to test their 
multipotency into mesodermal lineage in vitro. The cells were also 
cultured in hyaluronic acid 3D-matrix known to be supportive for 
chondrogenic differentiation. 
Results: The two hES-MP cell lines formed bone in an osteogenic 
assay and chondrogenic phenotype was demonstrated in pellet 
culture system although with poor ability of matrix production. When 
the cells were cultured in the hyaluronic acid scaffold the matrix 
production was increased and collagen expressions demonstrated 
by immunohistochemcal staining. 
Conclusions: The 3D hyaluronic acid environment seems to have 
a positive impact on chondrogenic differentiation in hESC derived 
mesenchymal progenitors. The osteogenic differentiation and 
DIPOESPHFOJD NBUSJY QSPEVDUJPO JO % DVMUVSF TZTUFNT DPO¾SNFE
the mesodermal origin of these cell lines. The hES-MP cell lines are 
a step towards chondrogenic and osteogenic differentiation of hES 
cell lines. 
